Stevanato Group SpA engages in the provision of drug containment, drug delivery, and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It operates through the following segments: Biopharmaceutical and Diagnostic Solutions, and Engineering segments. The Biopharmaceutical and Diagnostic Solutions segment includes all the products, processes, and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment deals with all the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology and diagnostic manufacturing processes. The company was founded by Giovanni Stevanato in 1949 and is headquartered in Piombino Dese, Italy.
Market Cap
$4.95B
P/E Ratio
39.26
1Y Stock Return
-32.48%
1Y Revenue Growth
5.26%
Dividend Yield
0.21%
Price to Book
3.4
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.
Finnhub
Mechanical performance was tested with two quantitative techniques, Vertical CompressionTest and Burst Test , measuring the maximum mechanical stress that a single vial can withstand before...
Finnhub
Stevanato Group S.p.A. Third Quarter 2024 Earnings Call Tuesday, November 5, 2024, 14:30 PM CET ...
SeekingAlpha
Stevanato's Q3 sales exceeded estimates, but EBITDA and EPS fell short due to under-utilization and higher costs. Read why we maintain STVN stock as a Buy.
Yahoo
The market rallied behind Stevanato Group S.p.A.'s ( NYSE:STVN ) stock, leading do a rise in the share price after its...
Yahoo
PIOMBINO DESE, Italy, November 11, 2024--Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment and delivery solutions to the pharmaceutical, biotechnology, and life sciences industries, announced today that it will participate in three upcoming investor conferences.
Yahoo
CPRX vs. STVN: Which Stock Is the Better Value Option?
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
AGS | -29.49% | $479.25M | +57.18% | 0.00% |
VITL | -23.23% | $1.32B | +142.79% | 0.00% |
UFI | -20.78% | $102.66M | -11.22% | 0.00% |
MQ | -17.87% | $1.96B | -36.48% | 0.00% |
LTM | -16.56% | $8.51B | -100.00% | <0.01% |
EOG | -14.79% | $76.03B | +10.19% | 2.70% |
DHC | -14.07% | $593.54M | +22.39% | 1.65% |
EMBC | -14.04% | $777.82M | -20.98% | 4.49% |
ACDC | -13.61% | $1.08B | -17.28% | 0.00% |
EGHT | -13.13% | $351.48M | -7.88% | 0.00% |
EQIX | -12.57% | $89.06B | +17.08% | 1.86% |
CLLS | -12.57% | $141.30M | -30.99% | 0.00% |
HY | -12.54% | $948.82M | +15.25% | 2.47% |
POAI | -12.51% | $4.29M | -78.60% | 0.00% |
CIM | -12.42% | $1.19B | -2.45% | 6.42% |
CCSI | -12.25% | $451.51M | +3.04% | 0.00% |
RES | -11.71% | $1.26B | -20.54% | 2.74% |
MAX | -11.58% | $681.47M | +32.02% | 0.00% |
AGR | -11.45% | $13.92B | +15.51% | 4.90% |
CARS | -11.41% | $1.20B | -2.01% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
WST | 35.72% | $22.02B | -13.73% | 0.27% |
INGR | 33.62% | $9.25B | +37.70% | 2.22% |
EPAM | 30.80% | $12.91B | -11.78% | 0.00% |
BGS | 29.73% | $503.48M | -32.20% | 12.01% |
ACEL | 29.46% | $940.36M | +12.85% | 0.00% |
MRSN | 29.13% | $274.24M | +40.51% | 0.00% |
HMN | 26.99% | $1.65B | +24.56% | 3.34% |
RAPT | 26.81% | $37.41M | -92.14% | 0.00% |
MSGE | 26.72% | $1.72B | +17.13% | 0.00% |
VMEO | 26.18% | $1.07B | +75.96% | 0.00% |
CIEN | 24.03% | $9.69B | +47.41% | 0.00% |
ABNB | 23.85% | $82.12B | +3.64% | 0.00% |
ARIS | 23.65% | $763.08M | +214.02% | 1.56% |
RGEN | 23.36% | $7.20B | -18.16% | 0.00% |
KFRC | 23.35% | $1.10B | -8.71% | 0.66% |
DUOL | 23.20% | $14.17B | +49.85% | 0.00% |
DXPE | 23.07% | $1.07B | +119.39% | 0.00% |
FWRD | 22.95% | $998.06M | -46.90% | 0.69% |
TRMB | 22.34% | $17.01B | +61.09% | 0.00% |
DIN | 22.30% | $491.55M | -27.79% | 6.39% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
NOAH | <0.01% | $775.22M | -3.69% | 8.96% |
CIVI | -0.02% | $4.91B | -21.31% | 3.94% |
ESNT | 0.02% | $5.93B | +16.81% | 1.96% |
TBRG | 0.03% | $244.47M | +52.66% | 0.00% |
FSM | 0.04% | $1.51B | +32.33% | 0.00% |
X | 0.04% | $8.76B | +13.32% | 0.51% |
CG | 0.05% | $18.29B | +59.36% | 3.41% |
AVAL | -0.06% | $791.37M | -4.11% | 7.14% |
IMO | 0.07% | $39.72B | +31.84% | 2.23% |
GME | 0.09% | $11.76B | +119.68% | 0.00% |
XYL | -0.09% | $29.70B | +21.00% | 1.15% |
HTLD | 0.10% | $962.37M | -5.03% | 0.65% |
PEN | -0.10% | $9.10B | +2.99% | 0.00% |
NBR | 0.11% | $694.91M | -21.77% | 0.00% |
BX | 0.11% | $224.27B | +74.81% | 1.86% |
CBOE | 0.12% | $21.46B | +15.84% | 1.11% |
BKD | 0.12% | $1.04B | -2.44% | 0.00% |
TNDM | -0.12% | $1.83B | +51.39% | 0.00% |
NTST | -0.13% | $1.30B | +2.31% | 5.22% |
CLF | -0.13% | $5.65B | -32.27% | 0.00% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
UNG | -13.86% | $908.80M | 1.06% |
VIXY | -13.82% | $195.31M | 0.85% |
TAIL | -8.53% | $67.98M | 0.59% |
BTAL | -8.25% | $388.04M | 1.43% |
BCI | -7.97% | $1.20B | 0.26% |
FLBL | -7.55% | $645.58M | 0.45% |
ULST | -6.94% | $535.47M | 0.2% |
SCHO | -6.39% | $11.10B | 0.03% |
SPTS | -6.38% | $5.71B | 0.03% |
USCI | -6.28% | $185.47M | 1.07% |
BCD | -6.28% | $245.02M | 0.3% |
DBE | -6.26% | $50.13M | 0.77% |
CMDY | -6.25% | $279.14M | 0.28% |
EQLS | -6.25% | $76.08M | 1% |
FTSM | -6.19% | $6.08B | 0.45% |
VTIP | -6.03% | $11.71B | 0.04% |
COMT | -5.95% | $829.06M | 0.48% |
TDTT | -5.94% | $1.84B | 0.18% |
FTSD | -5.91% | $171.68M | 0.25% |
HIGH | -5.79% | $302.78M | 0.51% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
EFAA | 31.56% | $117.38M | 0% |
RSPA | 25.51% | $273.87M | 0% |
IMOM | 19.74% | $80.57M | 0.39% |
QYLD | 19.09% | $8.25B | 0.61% |
HEDJ | 17.88% | $1.49B | 0.58% |
QQA | 17.84% | $135.01M | 0% |
BUG | 17.40% | $783.85M | 0.5% |
BUFR | 17.39% | $5.69B | 0.95% |
FTQI | 17.28% | $492.22M | 0.75% |
EWA | 17.22% | $1.44B | 0.5% |
CIBR | 17.16% | $6.98B | 0.59% |
SKYY | 17.14% | $3.41B | 0.6% |
IYT | 17.13% | $728.33M | 0.39% |
CLOU | 17.11% | $349.39M | 0.68% |
FFLC | 16.98% | $574.64M | 0.38% |
HACK | 16.94% | $1.80B | 0.6% |
ROBT | 16.93% | $441.35M | 0.65% |
XT | 16.92% | $3.38B | 0.46% |
XYLD | 16.91% | $2.89B | 0.6% |
ARTY | 16.90% | $624.02M | 0.47% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
DBO | -0.02% | $217.57M | 0.77% |
FIXD | -0.04% | $5.51B | 0.65% |
BLV | 0.04% | $5.68B | 0.04% |
VPU | 0.04% | $6.66B | 0.1% |
FISR | 0.07% | $307.49M | 0.5% |
XLP | 0.08% | $16.03B | 0.09% |
FBND | -0.08% | $15.84B | 0.36% |
MTBA | -0.10% | $1.56B | 0.15% |
SLVP | 0.10% | $228.48M | 0.39% |
PULS | 0.11% | $8.78B | 0.15% |
BBAG | -0.13% | $1.66B | 0.03% |
IYE | -0.13% | $1.35B | 0.39% |
SILJ | 0.14% | $945.80M | 0.69% |
GTO | -0.15% | $1.77B | 0.25% |
IEZ | 0.16% | $153.88M | 0.4% |
JCPB | 0.17% | $4.55B | 0.38% |
BOND | 0.21% | $5.01B | 0.58% |
IXC | -0.22% | $2.20B | 0.41% |
BGRN | 0.26% | $389.17M | 0.2% |
FXU | -0.28% | $341.08M | 0.64% |
Current Value
$18.101 Year Return
Current Value
$18.101 Year Return